Vontobel Holding Ltd. Purchases 1,503 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Vontobel Holding Ltd. boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 58.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,066 shares of the biotechnology company's stock after purchasing an additional 1,503 shares during the quarter. Vontobel Holding Ltd.'s holdings in Axon Enterprise were worth $1,625,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Vanguard Group Inc. grew its position in Axon Enterprise by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company's stock valued at $2,547,878,000 after purchasing an additional 212,401 shares during the period. Motley Fool Asset Management LLC increased its position in shares of Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company's stock worth $153,981,000 after acquiring an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. raised its holdings in shares of Axon Enterprise by 44.0% in the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company's stock worth $110,546,000 after acquiring an additional 114,800 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Axon Enterprise by 13.9% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company's stock valued at $108,496,000 after acquiring an additional 45,049 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its holdings in Axon Enterprise by 1.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 270,430 shares of the biotechnology company's stock worth $79,571,000 after purchasing an additional 4,365 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares of the company's stock, valued at approximately $11,500,916.82. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the transaction, the director now owns 26,259 shares of the company's stock, valued at $11,500,916.82. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 4,767 shares of Axon Enterprise stock in a transaction on Thursday, October 3rd. The stock was sold at an average price of $404.14, for a total transaction of $1,926,535.38. Following the sale, the chief executive officer now directly owns 2,925,060 shares of the company's stock, valued at $1,182,133,748.40. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 371,172 shares of company stock worth $137,000,162 in the last three months. Corporate insiders own 6.10% of the company's stock.

Axon Enterprise Stock Performance

Shares of AXON stock traded up $3.57 during trading on Friday, reaching $438.05. 228,792 shares of the company's stock traded hands, compared to its average volume of 521,796. Axon Enterprise, Inc. has a 1 year low of $199.29 and a 1 year high of $440.89. The firm's 50-day moving average is $388.71 and its 200 day moving average is $331.79. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $33.06 billion, a P/E ratio of 128.08, a PEG ratio of 11.74 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company's revenue for the quarter was up 34.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.80 earnings per share. Equities research analysts expect that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on AXON shares. Needham & Company LLC restated a "buy" rating and issued a $400.00 target price on shares of Axon Enterprise in a report on Wednesday, August 7th. Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a "buy" rating and a $385.00 target price for the company. Craig Hallum raised their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research report on Wednesday, August 7th. Bank of America initiated coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a "buy" rating and a $380.00 price objective for the company. Finally, Barclays increased their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $365.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.